Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer
NCT03001895Phase 2Completed
- Sponsor
- Jewish General Hospital
- Start
- Jul 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Jewish General Hospital. Started Jul 2017; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03001895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001895.